IDH Mutation Classification in Nonenhancing Gliomas: A Comparison of Habitat and Whole-Tumor Transfer Learning Strategies.

BACKGROUND: Isocitrate dehydrogenase (IDH) mutation status is an important biomarker for the diagnosis and management of nonenhancing gliomas, underscoring the need for noninvasive preoperative classification. PURPOSE: To compare the value of habitat…

Preview only. Read the full abstract at the source